Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-21

Clinical Trial Update: Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating PRGF supplementation after TMJ arthrocentesis in temporomandibular joint osteoarthritis; the study was terminated and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRGF (platelet-rich growth factor)

Snippet

Sponsor: University of Florida | Conditions: TMJ, Osteoarthritis | Phase 4 | Status: TERMINATED | Results posted: 2025-02-21